AFM
REPL icon

Anson Funds Management’s Replimune Group REPL Stock Holding History

Anson Funds Management’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-73,228
Closed -$617K – 201
2023
Q4 		$617K Buy
+73,228
New +$849K 0.08% 118

Other funds holding REPL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Anson Funds Management's REPL Position: Q1 2024 in Review

Anson Funds Management sold out of Replimune Group (REPL) in Q1 2024, closing a stake of 73,228 shares — an estimated $617K sold.

Anson Funds Management first reported a position in REPL in Q4 2023 and held it in 1 quarter. The position peaked at $617K in Q4 2023. 150 funds tracked by Wall St. Rank hold REPL as of Q1 2024.

  • Anson Funds Management reported no remaining Replimune Group position as of Q1 2024 after selling out during the quarter.
  • Anson Funds Management sold 73,228 Replimune Group shares in Q1 2024, an estimated $617K.
  • Anson Funds Management first reported a position in Replimune Group in Q4 2023 and held it in 1 quarter.
  • Anson Funds Management's Replimune Group position peaked at $617K in Q4 2023.
  • 150 funds tracked by Wall St. Rank held Replimune Group as of Q1 2024.

Based on Anson Funds Management's 13F filing for Q1 2024, filed 14 May 2024.